The road to personalised medicine in the NHS – where do we go from here?

Personalised medicine is one of the most exciting areas of healthcare, yet we know it can also be complex. That’s why Merck’s latest episode of NAVIGATE focuses on providing clarity and demystifying what personalised medicine is all about. If you’ve ever been curious about what personalised medicines could mean for patients and the NHS, then be sure to listen in to our latest episode of NAVIGATE!

In this episode, our Market Access director, Amerah Amin, was delighted to talk to Rachel Butler, Consultant Clinical Scientist and Chief Operating Officer at the North Thames Genomic Laboratory Hub and Dr Alastair Greystoke, Honorary Medical Oncologist at Newcastle’s Northern Centre for Cancer Care. Amerah virtually sat down with Rachel and Alastair to discuss what the priorities, challenges and opportunities are to deliver personalised medicine in the NHS.